de Northern Trust Pfizer PFE Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 1423 M | Vender |
59,084,573
-2,941,979
| -5% | -USD 77 M | 0.17% | 100 |
|
|
2026
Q1 | USD 1742 M | Vender |
62,026,552
-1,224,037
| -2% | -USD 32.6 M | 0.23% | 76 |
|
|
2025
Q4 | USD 1575 M | Vender |
63,250,589
-769,218
| -1% | -USD 19.4 M | 0.2% | 93 |
|
|
2025
Q3 | USD 1631 M | Comprar |
64,019,807
+869,175
| +1% | +USD 21.5 M | 0.21% | 86 |
|
|
2025
Q2 | USD 1531 M | Comprar |
63,150,632
+824,675
| +1% | +USD 19.2 M | 0.21% | 87 |
|
|
2025
Q1 | USD 1579 M | Comprar |
62,325,957
+3,943,397
| +7% | +USD 103 M | 0.23% | 81 |
|
|
2024
Q4 | USD 1549 M | Comprar |
58,382,560
+4,167,222
| +8% | +USD 113 M | 0.22% | 79 |
|
|
2024
Q3 | USD 1569 M | Vender |
54,215,338
-2,444,296
| -4% | -USD 71.3 M | 0.26% | 65 |
|
|
2024
Q2 | USD 1585 M | Vender |
56,659,634
-1,075,190
| -2% | -USD 29.6 M | 0.27% | 59 |
|
|
2024
Q1 | USD 1602 M | Vender |
57,734,824
-2,070,986
| -3% | -USD 57.5 M | 0.28% | 62 |
|
|
2023
Q4 | USD 1722 M | Vender |
59,805,810
-3,306,484
| -5% | -USD 100 M | 0.31% | 55 |
|
|
2023
Q3 | USD 2093 M | Comprar |
63,112,294
+37,110
| +0.1% | +USD 1.31 M | 0.41% | 36 |
|
|
2023
Q2 | USD 2314 M | Vender |
63,075,184
-3,104,916
| -5% | -USD 121 M | 0.44% | 35 |
|
|
2023
Q1 | USD 2700 M | Vender |
66,180,100
-551,327
| -0.8% | -USD 23.8 M | 0.54% | 29 |
|
|
2022
Q4 | USD 3419 M | Comprar |
66,731,427
+143,652
| +0.2% | +USD 6.89 M | 0.72% | 20 |
|
|
2022
Q3 | USD 2914 M | Vender |
66,587,775
-390,573
| -0.6% | -USD 19 M | 0.67% | 22 |
|
|
2022
Q2 | USD 3512 M | Comprar |
66,978,348
+467,468
| +0.7% | +USD 23.8 M | 0.75% | 21 |
|
|
2022
Q1 | USD 3443 M | Vender |
66,510,880
-1,481,305
| -2% | -USD 76.9 M | 0.61% | 22 |
|
|
2021
Q4 | USD 4015 M | Comprar |
67,992,185
+153,174
| +0.2% | +USD 7.59 M | 0.66% | 18 |
|
|
2021
Q3 | USD 2918 M | Comprar |
67,839,011
+3,588,619
| +6% | +USD 159 M | 0.52% | 27 |
|
|
2021
Q2 | USD 2516 M | Vender |
64,250,392
-802,659
| -1% | -USD 31.2 M | 0.44% | 37 |
|
|
2021
Q1 | USD 2357 M | Vender |
65,053,051
-1,665,724
| -2% | -USD 59.1 M | 0.44% | 40 |
|
|
2020
Q4 | USD 2456 M | Vender |
66,718,775
-5,615,494
| -8% | -USD 206 M | 0.48% | 35 |
|
|
2020
Q3 | USD 2519 M | Vender |
72,334,269
-111,380
| -0.2% | -USD 3.9 M | 0.55% | 27 |
|
|
2020
Q2 | USD 2248 M | Vender |
72,445,649
-1,351,271
| -2% | -USD 45.9 M | 0.53% | 34 |
|
|
2020
Q1 | USD 2285 M | Vender |
73,796,920
-1,230,026
| -2% | -USD 41.9 M | 0.66% | 21 |
|
|
2019
Q4 | USD 2789 M | Vender |
75,026,946
-1,909,104
| -2% | -USD 68 M | 0.62% | 26 |
|
|
2019
Q3 | USD 2623 M | Vender |
76,936,050
-3,633,974
| -5% | -USD 132 M | 0.63% | 27 |
|
|
2019
Q2 | USD 3311 M | Vender |
80,570,024
-265,674
| -0.3% | -USD 10.5 M | 0.79% | 19 |
|
|
2019
Q1 | USD 3257 M | Vender |
80,835,698
-1,291,578
| -2% | -USD 51.7 M | 0.8% | 16 |
|
|
2018
Q4 | USD 3401 M | Comprar |
82,127,276
+3,136,694
| +4% | +USD 130 M | 0.95% | 12 |
|
|
2018
Q3 | USD 3303 M | Vender |
78,990,582
-1,269,359
| -2% | -USD 48.9 M | 0.81% | 13 |
|
|
2018
Q2 | USD 2763 M | Vender |
80,259,941
-2,221,521
| -3% | -USD 75.9 M | 0.7% | 19 |
|
|
2018
Q1 | USD 2777 M | Vender |
82,481,462
-1,586,000
| -2% | -USD 54.5 M | 0.72% | 18 |
|
|
2017
Q4 | USD 2889 M | Vender |
84,067,462
-1,391,134
| -2% | -USD 47.4 M | 0.73% | 18 |
|
|
2017
Q3 | USD 2895 M | Comprar |
85,458,596
+3,503,694
| +4% | +USD 113 M | 0.75% | 18 |
|
|
2017
Q2 | USD 2612 M | Vender |
81,954,902
-1,280,088
| -2% | -USD 40.4 M | 0.73% | 20 |
|
|
2017
Q1 | USD 2702 M | Vender |
83,234,990
-1,431,792
| -2% | -USD 45.1 M | 0.78% | 18 |
|
|
2016
Q4 | USD 2609 M | Vender |
84,666,782
-2,058,035
| -2% | -USD 62.8 M | 0.8% | 19 |
|
|
2016
Q3 | USD 2787 M | Comprar |
86,724,817
+624,785
| +0.7% | +USD 20.9 M | 0.87% | 15 |
|
|
2016
Q2 | USD 2876 M | Vender |
86,100,032
-904,273
| -1% | -USD 28.9 M | 0.93% | 12 |
|
|
2016
Q1 | USD 2452 M | Vender |
87,004,305
-326,642
| -0.4% | -USD 9.33 M | 0.81% | 18 |
|
|
2015
Q4 | USD 2675 M | Vender |
87,330,947
-5,919,547
| -6% | -USD 186 M | 0.89% | 14 |
|
|
2015
Q3 | USD 2779 M | Vender |
93,250,494
-2,470,242
| -3% | -USD 79.2 M | 0.93% | 10 |
|
|
2015
Q2 | USD 3045 M | Vender |
95,720,736
-481,980
| -0.5% | -USD 15.7 M | 0.92% | 10 |
|
|
2015
Q1 | USD 3175 M | Vender |
96,202,716
-2,427,633
| -2% | -USD 77.2 M | 0.96% | 11 |
|
|
2014
Q4 | USD 2915 M | Vender |
98,630,349
-350,875
| -0.4% | -USD 10.1 M | 0.88% | 13 |
|
|
2014
Q3 | USD 2777 M | Vender |
98,981,224
-1,429,039
| -1% | -USD 40.1 M | 0.87% | 14 |
|
|
2014
Q2 | USD 2827 M | Vender |
100,410,263
-1,017,616
| -1% | -USD 29 M | 0.88% | 13 |
|
|
2014
Q1 | USD 3091 M | Vender |
101,427,879
-2,463,690
| -2% | -USD 73.5 M | 0.97% | 11 |
|
|
2013
Q4 | USD 3019 M | Vender |
103,891,569
-927,545
| -0.9% | -USD 27 M | 0.97% | 12 |
|
|
2013
Q3 | USD 2857 M | Vender |
104,819,114
-3,922,509
| -4% | -USD 107 M | 1.01% | 13 |
|
|
2013
Q2 | USD 2890 M | Comprar |
+108,741,623
| Nuevas | +USD 3005 M | 1.05% | 12 |
|
Otros fondos que tienen PFE en su cartera
Posición de Northern Trust en PFE: resumen de T2 2026
Northern Trust redujo su participación en Pfizer (PFE) en 4.7% durante T2 2026, al vender acciones por un valor estimado de USD 77 M, y conservó 59,084,573 acciones valuadas en USD 1423 M. La posición representa 0.17% de la cartera y ocupa el puesto #100.
Northern Trust reportó por primera vez una posición en PFE en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. La posición alcanzó su máximo de USD 4015 M en T4 2021. Al cierre de T2 2026, 2,848 fondos que sigue Wall St. Rank mantienen una posición en PFE.
- Al cierre de T2 2026, Northern Trust tenía 59,084,573 acciones de Pfizer con un valor de USD 1423 M.
- Northern Trust vendió 2,941,979 acciones de Pfizer en T2 2026, por un valor estimado de USD 77 M.
- Pfizer representó 0.17% de la cartera de Northern Trust en T2 2026 y fue su posición número 100.
- Northern Trust reportó por primera vez una posición en Pfizer en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- La posición de Northern Trust en Pfizer alcanzó su máximo de USD 4015 M en T4 2021.
- Al cierre de T2 2026, 2,848 fondos que sigue Wall St. Rank tenían Pfizer en cartera.
Según el Informe 13F de Northern Trust correspondiente a T2 2026, presentado el 13 ago 2026.